Format

Send to

Choose Destination
Medicine (Baltimore). 2017 Apr;96(14):e6275. doi: 10.1097/MD.0000000000006275.

Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.

Author information

1
aDivision of Allergy and Infectious Diseases, University of Washington, Seattle, WA bDivision of Infectious Diseases cDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL dDepartment of Medicine, University of California San Diego, San Diego eGilead Sciences, Foster City, CA fFenway Health Center, Harvard Medical School, Boston, MA gDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC hBristol-Myers Squibb, Princeton, NJ.

Abstract

We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.

PMID:
28383402
PMCID:
PMC5411186
DOI:
10.1097/MD.0000000000006275
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center